NLTX - Neoleukin Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Neoleukin Therapeutics's activity chart (see below) currently has 29 price targets and 34 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 56.52% of the time, taking 286.17 days on average.

Most recent stock forecast was given by from MIZUHO on 09-May-2023. First documented stock forecast 17-Mar-2015.

Best performing analysts who are covering NLTX - Neoleukin Therapeutics:

Michael Ulz William Tanner Ritu Baral Bill Maughan

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-Nov-2022

$7.5

3 years 6 months 12 days ago
(09-May-2023)

2/2 (100%)

$-10.3 (-57.87%)

371

Hold Since 16-Nov-2022

4 years 5 days ago
(16-Nov-2022)

1/1 (100%)

$-130.4 (-54.24%)

584

Buy Since 06-Jan-2021

$4.5

4 years 6 days ago
(15-Nov-2022)

2/2 (100%)

$-4 (-47.06%)

379

Hold Since 15-Nov-2022

$100

4 years 6 days ago
(15-Nov-2022)

1/1 (100%)

$-122.2 (-55.00%)

643

Buy Since 06-Jul-2022

$20

$200

4 years 6 days ago
(14-Nov-2022)

0/2 (0%)

$11.5 (135.29%)

Show more analysts

Please expand the browser size to see the chart

What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?

On average it took 286 days for the stock forecasts to be reached, with an average price target met ratio of 56.52%.

Which analyst most recently updated their price target on NLTX (Neoleukin Therapeutics)?

Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?

has 0 price targets and 0 ratings on NLTX

Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?

Tyler Van Buren with the highest potential upside of $584.9

Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?

Benjamin Burnett with the lowest potential downside of -$10.6
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?